Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

May 31, 2024

Study Completion Date

July 31, 2024

Conditions
Human Immunodeficiency Virus (HIV)TuberculosisCoinfection
Interventions
OTHER

Observational PK study

Effect of antituberculosis treatment, age and genetic factors on intracellular TFV-DP and FTC-TP concentrations

Trial Locations (1)

Unknown

Kwame Nkrumah University of Science and Technology, Kumasi

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Florida

OTHER

NCT03800394 - Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents | Biotech Hunter | Biotech Hunter